Definium Therapeutics, Inc. (DFTX)
17.55
-0.21
(-1.18%)
USD |
NASDAQ |
Mar 05, 16:00
17.56
+0.01
(+0.06%)
After-Hours: 20:00
Definium Therapeutics Research and Development Expense (Annual) : 117.66M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pulse Biosciences, Inc. | 44.72M |
| RxSight, Inc. | 38.55M |
| Plus Therapeutics, Inc. | 10.58M |
| Viridian Therapeutics, Inc. | 338.47M |
| Nutriband, Inc. | 3.119M |